Highlights
In this application note, the RASTRUM™ Platform, developed by Inventia Life Science, has been combined with Operetta CLS™ high-content analysis system and customised machine learning algorithms to demonstrate the utility of cell painting-based phenotypic screening of advanced cell models in synthetic matrices with U-87MG glioblastoma cells.